Cargando…
PB2196: EQUATOR: A PIVOTAL PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ITOLIZUMAB IN COMBINATION WITH CORTICOSTEROIDS FOR THE INITIAL TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431612/ http://dx.doi.org/10.1097/01.HS9.0000851612.99253.8a |
| _version_ | 1784780103308279808 |
|---|---|
| author | Koreth, J. Kean, L. Chinn, L. Acevedo, L. M. Bandman, O. Rothman, J. Connelly, S. Thomas, D. Cutler, C. |
| author_facet | Koreth, J. Kean, L. Chinn, L. Acevedo, L. M. Bandman, O. Rothman, J. Connelly, S. Thomas, D. Cutler, C. |
| author_sort | Koreth, J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431612 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94316122022-08-31 PB2196: EQUATOR: A PIVOTAL PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ITOLIZUMAB IN COMBINATION WITH CORTICOSTEROIDS FOR THE INITIAL TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE Koreth, J. Kean, L. Chinn, L. Acevedo, L. M. Bandman, O. Rothman, J. Connelly, S. Thomas, D. Cutler, C. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431612/ http://dx.doi.org/10.1097/01.HS9.0000851612.99253.8a Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Koreth, J. Kean, L. Chinn, L. Acevedo, L. M. Bandman, O. Rothman, J. Connelly, S. Thomas, D. Cutler, C. PB2196: EQUATOR: A PIVOTAL PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ITOLIZUMAB IN COMBINATION WITH CORTICOSTEROIDS FOR THE INITIAL TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE |
| title | PB2196: EQUATOR: A PIVOTAL PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ITOLIZUMAB IN COMBINATION WITH CORTICOSTEROIDS FOR THE INITIAL TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE |
| title_full | PB2196: EQUATOR: A PIVOTAL PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ITOLIZUMAB IN COMBINATION WITH CORTICOSTEROIDS FOR THE INITIAL TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE |
| title_fullStr | PB2196: EQUATOR: A PIVOTAL PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ITOLIZUMAB IN COMBINATION WITH CORTICOSTEROIDS FOR THE INITIAL TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE |
| title_full_unstemmed | PB2196: EQUATOR: A PIVOTAL PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ITOLIZUMAB IN COMBINATION WITH CORTICOSTEROIDS FOR THE INITIAL TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE |
| title_short | PB2196: EQUATOR: A PIVOTAL PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ITOLIZUMAB IN COMBINATION WITH CORTICOSTEROIDS FOR THE INITIAL TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE |
| title_sort | pb2196: equator: a pivotal phase 3 double-blind, randomized, placebo-controlled study of itolizumab in combination with corticosteroids for the initial treatment of acute graft-versus-host disease |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431612/ http://dx.doi.org/10.1097/01.HS9.0000851612.99253.8a |
| work_keys_str_mv | AT korethj pb2196equatorapivotalphase3doubleblindrandomizedplacebocontrolledstudyofitolizumabincombinationwithcorticosteroidsfortheinitialtreatmentofacutegraftversushostdisease AT keanl pb2196equatorapivotalphase3doubleblindrandomizedplacebocontrolledstudyofitolizumabincombinationwithcorticosteroidsfortheinitialtreatmentofacutegraftversushostdisease AT chinnl pb2196equatorapivotalphase3doubleblindrandomizedplacebocontrolledstudyofitolizumabincombinationwithcorticosteroidsfortheinitialtreatmentofacutegraftversushostdisease AT acevedolm pb2196equatorapivotalphase3doubleblindrandomizedplacebocontrolledstudyofitolizumabincombinationwithcorticosteroidsfortheinitialtreatmentofacutegraftversushostdisease AT bandmano pb2196equatorapivotalphase3doubleblindrandomizedplacebocontrolledstudyofitolizumabincombinationwithcorticosteroidsfortheinitialtreatmentofacutegraftversushostdisease AT rothmanj pb2196equatorapivotalphase3doubleblindrandomizedplacebocontrolledstudyofitolizumabincombinationwithcorticosteroidsfortheinitialtreatmentofacutegraftversushostdisease AT connellys pb2196equatorapivotalphase3doubleblindrandomizedplacebocontrolledstudyofitolizumabincombinationwithcorticosteroidsfortheinitialtreatmentofacutegraftversushostdisease AT thomasd pb2196equatorapivotalphase3doubleblindrandomizedplacebocontrolledstudyofitolizumabincombinationwithcorticosteroidsfortheinitialtreatmentofacutegraftversushostdisease AT cutlerc pb2196equatorapivotalphase3doubleblindrandomizedplacebocontrolledstudyofitolizumabincombinationwithcorticosteroidsfortheinitialtreatmentofacutegraftversushostdisease |